Needham analyst Mike Matson downgrades NeoGenomics (NASDAQ:NEO) from Buy to Hold.
Citigroup Maintains Buy on AutoZone, Raises Price Target to $2520
Citigroup analyst Steven Zaccone maintains AutoZone (NYSE:AZO) with a Buy and raises the price target from $2250 to $2520.